ID: h-13ea09f59f
Hypothesis
Basal forebrain NGF/TrkA trophic failure is an upstream trigger that makes cholinergic neurons permissive to later amyloid and tau spread
Loss of retrograde NGF-TrkA support could destabilize basal-forebrain cholinergic neurons early, lowering cortical acetylcholine tone and secondarily biasing APP processing and tau susceptibility.
EvidencePending (0%)📖 7 cit🗣 1 debates✓ 7 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
Loss of retrograde NGF-TrkA support could destabilize basal-forebrain cholinergic neurons early, lowering cortical acetylcholine tone and secondarily biasing APP processing and tau susceptibility. This remains plausible and clinically relevant, but current support is more inferential than decisive.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Cortical NGF Production<br/>Target-Derived Trophic Factor"]
B["NGF Retrograde Transport<br/>Axonal NTRK1 / TrkA Complex"]
C["Basal Forebrain Cholinergic Neurons<br/>TrkA Survival Signaling"]
D["PI3K-Akt / MAPK Survival Cascade<br/>CREB-Mediated Gene Expression"]
E["ChAT / VAChT Maintenance<br/>Cholinergic Phenotype Preservation"]
F["APP Processing Shift<br/>sAPP-alpha Neuroprotective Fragment"]
G["NGF Transport Failure<br/>TrkA-p75NTR Imbalance"]
A --> B
B --> C
C --> D
D --> E
D --> F
G -.->|"disrupts"| B
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style E fill:#1b5e20,stroke:#81c784,color:#81c784
style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a⚖️ Evidence
⚖️ Evidence Matrix7 supports2 contradicts
Supports
Human basal forebrain cholinergic vulnerability is well documented and compatible with early trophic-signaling failure.
Supports
Clinical neurotrophin translation work suggests degenerating human neurons can remain trophically responsive, preserving therapeutic relevance.
Supports
Exercise therapy to prevent and treat Alzheimer's disease.
Supports
Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study.
Supports
Aberrant tau phosphorylation and neurite retraction during NGF deprivation in PC12 cells.
Supports
Alzheimer's Disease: An Update and Insights Into Pathophysiology.
Supports
Depression like-behavior and memory loss induced by methylglyoxal is associated with tryptophan depletion and oxidative stress: a new in vivo model of neurodegeneration.
Contradicts
Reduced NGF/TrkA signaling may be secondary to tau, synapse loss, or endosomal stress rather than the initiating lesion.
Contradicts
No validated circulating biomarker currently establishes NGF/TrkA failure as preceding soluble amyloid or seed-competent tau in humans.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — NGF
No curated PDB or AlphaFold mapping for NGF yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for NGF, NTRK1, APP from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for NGF, NTRK1, APP.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▼ 0.5%
Volatility
Low
0.0026
Events (7d)
2
Price History
▼8.8%💾 Resource Usage
LLM Tokens
19,162
$0.0575
Total Cost
$0.0575
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF we administer NGF (2.5 μg/day) or a TrkA agonist (e.g., 7,8-dihydroxyflavone, 20 mg/kg/day) directly into the basal forebrain of 3xTg-AD mice starting at 3 months of age for 3 months, THEN cortical | ≥40% reduction in cortical Aβ42 concentration and ≥40% reduction in phospho-tau (Ser396) levels measured by ELISA and western blot at 12 months of age. | — no observation — | pending | 0.55 |
| IF we cross 5xFAD mice with Chat-Cre;TrkA-flox/flox mice to achieve selective TrkA deletion in basal forebrain cholinergic neurons, THEN these mice will exhibit accelerated cortical amyloid plaque dep | ≥50% increase in cortical Thioflavin-S+ plaque burden and ≥2-fold increase in AT8+ neurons in cortex at 6 months of age. | — no observation — | pending | 0.45 |
🔮 Falsifiable Predictions (2)
pendingconf 55%
IF we administer NGF (2.5 μg/day) or a TrkA agonist (e.g., 7,8-dihydroxyflavone, 20 mg/kg/day) directly into the basal forebrain of 3xTg-AD mice starting at 3 months of age for 3 months, THEN cortical Aβ42 levels and tau phosphorylation at Ser396 will be reduced by ≥40% at 12 months compared to vehi
Predicted outcome: ≥40% reduction in cortical Aβ42 concentration and ≥40% reduction in phospho-tau (Ser396) levels measured by ELISA and western blot at 12 months of age
Falsification: No significant reduction (p>0.05) or actual increase in Aβ42 or phospho-tau levels in NGF/TrkA agonist-treated mice versus vehicle controls, indicating trophic support does not modulate amyloid or tau
pendingconf 45%
IF we cross 5xFAD mice with Chat-Cre;TrkA-flox/flox mice to achieve selective TrkA deletion in basal forebrain cholinergic neurons, THEN these mice will exhibit accelerated cortical amyloid plaque deposition (≥50% increase) and elevated phospho-tau (AT8+) at 6 months compared to 5xFAD;Chat-Cre contr
Predicted outcome: ≥50% increase in cortical Thioflavin-S+ plaque burden and ≥2-fold increase in AT8+ neurons in cortex at 6 months of age.
Falsification: No acceleration of amyloid or tau pathology in cholinergic TrkA knockout mice versus controls, or equivalent pathology suggesting NGF/TrkA signaling is not upstream of amyloid/tau susceptibility.
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.